Yao K, Iguchi Y, Sato K, Nishiyama K, Suzuki T, Yamamoto K, Okamoto M
Department of Otorhinolaryngology, Kitasato University School of Medicine, Kanagawa, Japan.
Am J Rhinol. 2001 Nov-Dec;15(6):395-402.
To investigate the background of the effectiveness of trichloroacetic acid (TCA) treatment, we examined the localization of thymus and activation-regulated chemokine (TARC) on allergic inferior turbinate mucosa using immunohistological methods. After obtaining informed consent, only one side of the inferior turbinate was treated with 80% (wt/vol) TCA solution under topical anesthesia using 4% lidocaine with epinephrine in 19 cases of allergic rhinitis. Among those, 17 cases did not show clinical improvement and underwent nasal septal reconstruction surgery and turbinectomy. Bilateral inferior turbinate specimens were obtained. The untreated turbinate specimens showed positive TARC findings. The positive findings were confirmed in the outer side of cytoplasm in the stratified ciliated columnar epithelium but not in the goblet cell. In the lamina propria, the glandular tissue and afew of the infiltrated lymphocytes just beneath the epithelium up to the depth of 120 microm were found TARC-positive (TARC+). The average number of positive cells in one microscopic visual field using 100x magnification was 3.97 +/- 4.04. On the other hand, the epithelium of the TCA-treated side showed positive findings only in two cases. The TCA-treated side also showed a relative decrease in infiltrated cells. Even in areas where there still were infiltrated cells, they were confirmed to be TARC-negative (TARC-) after TCA treatment. It is considered that the regenerated epithelium after TCA treatment originates from the glandular epithelium with negative TARC expression existing in the area deeper than a 120-microm level and that this immunohistological change would lead to the effectiveness of TCA treatment.
为了研究三氯乙酸(TCA)治疗有效性的背景,我们采用免疫组织学方法检测了变应性下鼻甲黏膜中胸腺和活化调节趋化因子(TARC)的定位。在获得知情同意后,对19例变应性鼻炎患者在局部麻醉下使用含肾上腺素的4%利多卡因,仅在下鼻甲的一侧用80%(重量/体积)TCA溶液进行治疗。其中,17例未显示临床改善,接受了鼻中隔重建手术和鼻甲切除术。获取了双侧下鼻甲标本。未治疗的鼻甲标本TARC检测呈阳性。阳性结果在复层纤毛柱状上皮细胞质外侧得到证实,但杯状细胞中未发现。在固有层中,发现腺组织以及上皮下方直至120微米深度的少量浸润淋巴细胞TARC呈阳性(TARC+)。使用100倍放大倍数在一个显微镜视野中的阳性细胞平均数量为3.97±4.04。另一方面,TCA治疗侧的上皮仅在2例中显示阳性结果。TCA治疗侧浸润细胞也相对减少。即使在仍有浸润细胞的区域,TCA治疗后证实它们为TARC阴性(TARC-)。据认为,TCA治疗后再生的上皮起源于120微米深度以下区域存在的TARC表达阴性的腺上皮,这种免疫组织学变化导致了TCA治疗的有效性。